Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Giant Cell Tumor of Bone × Vitamin D × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Insulin Resistance 1 Inflammation 1 Giant Cell Tumor of Bone 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Breast Neoplasms 1 Biomarker Change Linked to Breast Cancer 1

Interventions

Vitamin D 1 Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04255576 2022-10-14

Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone

Shanghai JMT-Bio Inc.

Phase 1/2 Unknown

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡